Subtenon injection of bevacizumab for retinal vein occulusion

Subtenon injection of bevacizumab for retinal vein occulusion - Subtenon injection of bevacizumab for retinal vein occulusion

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005254

Enrollment

Registered

2011-03-16

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinal vein occulusion

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with macular edema. Not treated or more than 3 months passed after the other teatment.

Exclusion criteria

Exclusion criteria: Post vitrectomy

Design outcomes

Primary

Measure	Time frame
retinal thickness, visual acuity, count of injection	—

Countries

Japan

Outcome results